1213670-22-4

Upstream product

• 265644-03-9 2,5-difluorobenzohydrazide 
• 1261174-79-1 3,6-dichloro-4-(1,1-dimethylethyl-d9)-pyridazine 

Downstream Products

• 1213669-91-0 7-(tert-butyl-d9)-3-(2,5-difluorophenyl)-6-((1-methyl-1H-1,2,4-triazol-5-yl)methoxy)-[1,2,4]triazolo[4,3-b]pyridazine 
• 1213669-96-5 7-(tert-butyl-d9)-3-(2,5-difluorophenyl)-6-((1-(methyl-d3)-1H-1,2,4-triazol-5-yl)-1,1-d2-methoxy)-[1,2,4]triazolo[4,3-b]pyridazine 
• 1213669-93-2 7-(tert-butyl-d9)-3-(2,5-difluorophenyl)-6-((1-(methyl-d3)-1H-1,2,4-triazol-5-yl)methoxy)-[1,2,4]triazolo[4,3-b]pyridazine 

Relevant academic research and scientific papers

SUBSTITUTED TRIAZOLO-PYRIDAZINE DERIVATIVES

This invention relates to novel substituted triazolo-pyridazines, their derivatives, and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering an α1 -GABA-A receptor antagonist and/or a α2, α3 and α5 GABA-A receptor agonist.